The Safety and Tolerability of Alpha-1 MP In Subjects With Alpha-1-Antitrypsin (AAT) Deficiency - No Study Results Posted

The Safety and Tolerability of Alpha-1 MP In Subjects With Alpha-1-Antitrypsin (AAT) Deficiency (STAMP)

This study has been completed.

Study NCT00301366 Information provided by Talecris Biotherapeutics

First Received: March 8, 2006 Last Updated: September 26, 2008 History of Changes

No Study Results Posted for this Study

Study Status:	This study has been completed.
Study Completion Date:	March 2007
Estimated Primary Completion Date:	No date given